Zumutor
is a Massachusetts-based immuno-oncology company that develops and commercializes NK-cell therapeutics for the treatment of prostate cancer... Read moreZumutor
is a Massachusetts-based immuno-oncology company that develops and commercializes NK-cell therapeutics for the treatment of prostate cancer... Read more
News
Jun 12, 2024
Kashmir Newsline
Zumutor: Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in-Class Anti LLT1 Antibody
Aug 17, 2023
IndiaMedToday
Zumutor: Zumutor Biologics announces FDA clearance of IND application of ZM008 to treat cancer
Feb 16, 2023
Zumutor Blog
Zumutor Blog Zumutor receives the US patent for its novel biologic ZM008
Jul 05, 2022
Zumutor Blog
Zumutor Blog Zumutor Receives FDA Response on Pre-Investigational New Drug (PIND) Application
Jul 05, 2022
Zumutor Blog
Zumutor Blog Abrogation of natural killer cell check point pathway LLT1/CD161 by novel anti LLT1 antibody ZM008 and its therapeutic applications in solid cancers.
Dec 13, 2021
BW Disrupt
Zumutor: Biotechnology Startup Zumutor Biologics Raises $6.2M
Dec 13, 2021
firstword pharma
Zumutor: Biotechnology startup Zumutor Biologics raises $6.2M for oncology molecule
Dec 09, 2021
Inc42 Magazine
Zumutor: Biotech Startup Zumutor Raises $6.2 Mn Funding From Siana Capital, Existing Investors
Sep 07, 2020
Zumutor Blog
Zumutor Blog Zumutor Biologics Announces Receipt of a Grant from The United States - India Science & Technology Endowment Board
Aug 18, 2020
Zumutor Blog
Zumutor Blog INABLRS - End to end antibody discovery platform
Zumutor Competitors
1
2
3
4
5
6
7
8
9
10